The independent source for health policy research, polling, and news.
7,441 - 7,460 of 15,458 Results
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the potential health impact of Hurricane Harvey on the Texas Gulf Coast, and what impact the relief effort in Washington could have on an already jampacked September agenda. Also this week: an interview with Elisabeth Rosenthal about why medical care costs so much.
Study suggests that many small tumors are sleepy, not deadly.
New research bolsters evidence that older adults with a sense of purpose are less likely to see their health decline with age. The question is: How does one cultivate more meaning and motivation in life?
The USA's first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
As lawmakers look for ways to stabilize the health law marketplaces, a number of ideas — such as expanding who can “buy in” to Medicare and Medicaid or pushing young adults off their parents’ plans into the marketplaces — might come into play.
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
Painkillers were never designed to be used over the long term, says the head of the Mayo Clinic’s pain rehabilitation center. Instead, patients should try other approaches, including relaxation therapies. But getting insurers to cover them might take coaxing.
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
An emergency department at New York-Presbyterian Hospital trains staff to recognize signs of elder abuse and help victims.
State lawmakers in California have an answer: legislation that would require your new insurer to keep paying for your current doctors even if they’re not in the network.
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Margot Sanger-Katz of The New York Times discuss the continuing efforts in Congress to “repeal and replace” the Affordable Care Act, upcoming open enrollment for individual insurance and Congress’ long health care to-do list for September.
Unhappy childhood experiences can drive people to join white supremacist groups, studies have found.
Politicians who tried to take health care benefits from their voters may face political consequences as constituents come to understand what’s at stake — in a way they didn’t a few months ago.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
As more patients receive hospice care at home, some of the powerful, addictive drugs they’re prescribed are ending up in the wrong hands.
The governors of both states signed abortion legislation last week. Texas will restrict insurance coverage while Oregon will require that it be covered.
A program that provides $400 million in federal funding for the visits expires next month. Advocates and providers hope it will be reauthorized with a higher level of funding — but some worry that might not happen.
© 2026 KFF